+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“The global Pulse Oximeters Market is anticipated to surpass USD 2 billion by 2020”, says Visiongain

07 November 2019

Visiongain has launched a new pharma report “Pulse Oximeters Market Report 2020-2030” by Type (Fingertip Pulse Oximeters, Handheld Pulse Oximeter, Pediatric Pulse Oximeters, Wrist-worn Pulse Oximeters), End user (Hospitals, Homecare, Other End Users), and Geography.

Global Pulse Oximeters marketis projected to grow on account of growing healthcare costs, increasing prevalence of target diseases and high unmet needs in developing economies among other contributing growth factors. The global market is projected to grow at a lucrative CAGR of ~6% over the forecast period 2020-2030 and anticipated to surpass USD 2 billion by 2020.

Factors such as an increase in the incidence of chronic diseases and an increase in the geriatric population are driving the global market for pulse oximeters. However, factors such as lack of awareness are expected to hamper the market growth in developing regions. Also, increasing healthcare spending in emerging nations and growing demand for proactive monitoring are anticipated to unleash opportunities for market players operating in this segment.

In 2018, the dominant market share was retained by hospitals and other healthcare facilities. The presence of a large patient pool with target diseases such as asthma, COPD, cardiac arrhythmia, and sleep apnea are raising demand for the global pulse oximeters market.

However, it is projected that the home care segment will rise rapidly over the forecast period from 2020-2030. The use of pulse oximeters in palliative care and hospice, especially in the case of pulmonary fibrosis, primarily to preserve patient comfort and improve the quality of life to support conventional treatment. Patients in hospice care are mostly tracked by fingertips and wrist pulse oximeters to monitor oxygen levels during emergencies.

Product design and R&D are some of the major techniques implemented by the major pulse oximeter companies operating in the market. For example, in the year 2018, Masimo declared the FDA approval of the RAS-45 Sensor rainbow acoustic monitoring system, a non-invasive respiration rate measurement system for neonatal and infant patients. The company launched Vital Signs Check Application in 2018, which is a robust application for patient data collection for the communication and monitoring system of Masimo Root patients.

The market is also witnessing dynamic trends of merger and acquisition. CareFusion Corp., for instance, purchased Vital Signs from GE Healthcare. Also, Philips purchased Xhale Assurance, Inc., a scale-up company that develops sensor technologies of the next generation in the year 2018. Under low perfusion pressure, their pulse oximetry sensor can monitor heart rate and blood oxygenation level, which is difficult to measure with a traditional fingertip pulse oximeter. The innovation will help Philips broaden its existing product range and differentiate its product portfolio.

North America dominated the pulse oximeters market in 2018 followed by the EU. Pulse oximetry testing can diagnose problems in the infants' first few weeks of life and can avoid the danger of serious complications.  Owing to it, the United States has made it obligatory for newborn screening until their hospital discharge.

The Asia Pacific is anticipated to see the fastest growth over the forecast period from 2020-2030. This is due to the growing awareness of patient safety during surgery and anesthesia, which has prompted governments and hospitals to include pulse oximeter in their treatments. Institutes like the Indian Society of Anesthesiologists promote the use of pulse oximeters during any anesthetic operation. Also, 2 patient monitoring devices were introduced in India on January 2017, namely SedLine Brain Function Monitoring and Rad-97 Pulse-CO Oximeter. Such services are projected to improve the capacity of clinicians.

Some of the major players operating in this industry are CareFusion Corp (Vyaire), CASMED, CONTEC MEDICAL SYSTEMS CO., LTD., Covidien, GE Healthcare, HALMA PLC, Koninklijke Philips NV, Masimo, Meditech Equipment Co., Ltd., MEDTRONIC PLC, Mindray Medical International Limited, NIHON KOHDEN CORPORATION, Nonin Medical, Inc., Opto Circuits (India) Limited, Smiths Medical, Spacelabs Healthcare, Welch Allyn, Zensorium, and Maxtec among other prominent players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

25 September 2023


Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

21 September 2023


Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033

The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.

14 September 2023


Visiongain Publishes Stem Cell Therapy Contract Manufacturing Market Report 2023-2033

The global Stem Cell Therapy Contract Manufacturing market was valued at US$2,495.1 million in 2022 and is projected to grow at a CAGR of 12.4% during the forecast period 2023-2033.

13 September 2023